Australia - English - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - sodium iodide(123i), quantity: 1 mbq - capsule - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium bicarbonate; sodium thiosulfate pentahydrate; sodium hydroxide; purified water; sunset yellow fcf; quinoline yellow; titanium dioxide; brilliant blue fcf; carmoisine; gelatin; ethanol; shellac; pharmaceutical glaze; carbon black - sodium iodide [123] diagnostic capsules are for diagnostic imaging of thyroid tissue.

United States - English - NLM (National Library of Medicine)

cardinal health - sodium citrate, unspecified form (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - sodium citrate (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s

United States - English - NLM (National Library of Medicine)

us medsource, llc - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection, usp is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments. sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis ― e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. but since an appreciable time interval may elapse before

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - as a vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - as a vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - as a vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

b.braun medical ltd - sodium dihydrogen phosphate dihydrate; zinc acetate dihydrate; soya oil; medium-chain triglycerides; l-isoleucine; l-leucine; l-lysine monohydrochloride; l-phenylalanine; l-threonine; l-valine; l-arginine; l-histidine hydrochloride monohydrate; l-alanine; l-aspartic acid; l-glutamic acid; glycine; l-proline; l-serine; calcium chloride dihydrate; magnesium acetate tetrahydrate; sodium acetate trihydrate; sodium chloride; potassium acetate; sodium hydroxide; glucose anhydrous; l-tryptophan; l-methionine - infusion - 1.872gram/1litre ; 5.264mg/1litre ; 20gram/1litre ; 20gram/1litre ; 2.256gram/1litre ; 3.008gram/1litre ; 2.728gram/1litre ; 3.368gram/1litre ; 1.744gram/1litre ; 2.496gram/1litre ; 2.592gram/1litre ; 1.624gram/1litre ; 4.656gram/1litre ; 1.44gram/1litre ; 3.368gram/1litre ; 1.584gram/1litre ; 3.264gram/1litre ; 2.88gram/1litre ; 470mg/1litre ; 686mg/1litre ; 222mg/1litre ; 402mg/1litre ; 2.747gram/1litre ; 781mg/1litre ; 120gram/1litre ; 544mg/1litre ; 1.88gram/1litre

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

b.braun medical ltd - sodium dihydrogen phosphate dihydrate; zinc acetate dihydrate; soya oil; medium-chain triglycerides; l-isoleucine; l-leucine; l-histidine hydrochloride monohydrate; l-alanine; l-aspartic acid; l-glutamic acid; glycine; l-proline; l-serine; calcium chloride dihydrate; magnesium acetate tetrahydrate; sodium acetate trihydrate; sodium chloride; potassium acetate; sodium hydroxide; l-lysine monohydrochloride; l-phenylalanine; l-threonine; l-valine; l-arginine; glucose anhydrous; l-tryptophan; l-methionine - infusion - 1.872gram/1litre ; 5.264mg/1litre ; 20gram/1litre ; 20gram/1litre ; 2.256gram/1litre ; 3.008gram/1litre ; 1.624gram/1litre ; 4.656gram/1litre ; 1.44gram/1litre ; 3.368gram/1litre ; 1.584gram/1litre ; 3.264gram/1litre ; 2.88gram/1litre ; 470mg/1litre ; 686mg/1litre ; 222mg/1litre ; 402mg/1litre ; 2.747gram/1litre ; 781mg/1litre ; 2.278gram/1litre ; 3.368gram/1litre ; 1.744gram/1litre ; 2.496gram/1litre ; 2.592gram/1litre ; 120gram/1litre ; 544mg/1litre ; 1.88gram/1litre

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.